Design, catalyst-free synthesis, DFT study and anticancer assessment of new 2,9-disubstituted purine-6-carboxamides.
2/5 보강
TL;DR
Flow cytometric analysis demonstrated that compound 6E significantly reduced p-PI3K levels, comparably to erlotinib, indicating effective suppression of EGFR-AKT downstream signaling at the cellular level, and molecular docking and MD simulations of the 6E-EGFR complex highlighted key amino acid interactions, corroborating the observed in vitro EGFR inhibition.
OpenAlex 토픽 ·
Biochemical and Molecular Research
Chronic Lymphocytic Leukemia Research
Quinazolinone synthesis and applications
Flow cytometric analysis demonstrated that compound 6E significantly reduced p-PI3K levels, comparably to erlotinib, indicating effective suppression of EGFR-AKT downstream signaling at the cellular l
APA
Joydeep Chatterjee, Shivkanya Madhavrao Bhujbal, et al. (2026). Design, catalyst-free synthesis, DFT study and anticancer assessment of new 2,9-disubstituted purine-6-carboxamides.. Bioorganic chemistry, 172, 109529. https://doi.org/10.1016/j.bioorg.2026.109529
MLA
Joydeep Chatterjee, et al.. "Design, catalyst-free synthesis, DFT study and anticancer assessment of new 2,9-disubstituted purine-6-carboxamides.." Bioorganic chemistry, vol. 172, 2026, pp. 109529.
PMID
41643510 ↗
Abstract 한글 요약
A green, catalyst-free synthesis of seventeen new 2,9-disubstituted purine-6-carboxamides (5 and 6) designed as EGFR inhibitors in high yields (85-93%) was accomplished. DFT analysis revealed the formation of an energetically favorable oxazolidine transition state with a lower activation barrier compared to alternative pathways, supporting the experimentally observed selectivity. In vitro anticancer activity against A549 lung cancer cells demonstrated dose-dependent growth inhibition, with IC₅₀ values ranging from 4.35 to 22.1 μM, and compound 6E emerged as the most potent derivative. It exhibited superior activity compared to the reference drug erlotinib, with a cellular IC₅₀ of 4.35 μM vs 11.83 μM and an EGFR enzymatic IC₅₀ of 105.96 nM vs 218.47 nM, indicating approximately 2-fold enhanced potency. Flow cytometric analysis demonstrated that compound 6E significantly reduced p-PI3K levels, comparably to erlotinib, indicating effective suppression of EGFR-AKT downstream signaling at the cellular level. Mechanistic investigations demonstrated that 6E increased ROS generation, induced mitochondrial depolarisation, and promoted apoptotic cell death. Further, molecular docking and MD simulations of the 6E-EGFR complex highlighted key amino acid interactions, corroborating the observed in vitro EGFR inhibition.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Antineoplastic Agents
- Drug Screening Assays
- Antitumor
- Structure-Activity Relationship
- Purines
- ErbB Receptors
- Molecular Structure
- Drug Design
- Density Functional Theory
- Cell Proliferation
- Dose-Response Relationship
- Drug
- Molecular Docking Simulation
- Protein Kinase Inhibitors
- Apoptosis
- A549 Cells
- Anticancer
- DFT
- EGFR inhibition
- Lung cancer
- Purine-6-carboxamides
- Synthesis
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.